COMPASS PATHWAYS PLC (CMPS) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $1.40M; Additional Paid in CapitalUSD $1.08B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-14.74M; Retained Earnings (Accumulated Deficit)USD $-985.19M.
- 2026-03-31: Common Stock, Value, IssuedUSD $1.39M; Additional Paid in CapitalUSD $1.07B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-14.79M; Retained Earnings (Accumulated Deficit)USD $-731.39M.
- 2025-12-31: Common Stock, Value, IssuedUSD $973.00K; Additional Paid in CapitalUSD $783.56M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-14.79M; Retained Earnings (Accumulated Deficit)USD $-822.59M.
- 2025-09-30: Common Stock, Value, IssuedUSD $973.00K; Additional Paid in CapitalUSD $780.52M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-15.19M; Retained Earnings (Accumulated Deficit)USD $-728.72M.
COMPASS PATHWAYS PLC Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.40M | $1.08B | $-14.74M | $-985.19M | $84.53M | 3 month · $4.03M | (m) |
| 2026-03-31 | $1.39M | $1.07B | $-14.79M | $-731.39M | $326.69M | 3 month · $2.90M | (m) |
| 2025-12-31 | $973.00K | $783.56M | $-14.79M | $-822.59M | $-52.85M | 12 month · $13.59M | (m) |
| 2025-09-30 | $973.00K | $780.52M | $-15.19M | $-728.72M | $37.59M | 3 month · $3.21M | (m) |
| 2025-06-30 | $946.00K | $767.19M | $-14.58M | $-591.00M | $162.56M | 3 month · $3.60M | (m) |
| 2025-03-31 | $938.00K | $763.44M | $-16.31M | $-552.60M | $195.47M | 3 month · $3.94M | (m) |
| 2024-12-31 | $702.00K | $704.92M | $-16.19M | $-534.73M | $154.69M | 12 month · $19.52M | 12 month · $37.26M |
| 2024-09-30 | $699.00K | $700.27M | $-16.54M | $-491.40M | $193.03M | 3 month · $4.97M | (m) |
| 2024-06-30 | $699.00K | $695.35M | $-16.88M | $-452.90M | $226.27M | 3 month · $4.92M | (m) |
| 2024-03-31 | $699.00K | $690.22M | $-16.96M | $-414.80M | $259.16M | 3 month · $5.13M | (m) |
| 2023-12-31 | $635.00K | $621.64M | $-16.93M | $-379.61M | $225.74M | 12 month · $17.28M | 12 month · $687.00K |
| 2023-09-30 | (m) | $617.16M | $-17.47M | $-347.08M | $253.25M | 3 month · $4.45M | (m) |
| 2023-06-30 | (m) | $496.34M | $-16.73M | $-313.69M | $166.40M | 3 month · $4.56M | 3 month · $687.00K |
| 2023-03-31 | (m) | $463.97M | $-17.45M | $-285.35M | $161.64M | 3 month · $4.07M | (m) |
| 2022-12-31 | (m) | $458.82M | $-16.87M | $-261.15M | $181.28M | 12 month · $13.12M | (m) |
| 2022-09-30 | (m) | $454.96M | $-30.64M | $-230.22M | $194.56M | 3 month · $3.50M | (m) |
| 2022-06-30 | (m) | $451.45M | $-15.49M | $-211.85M | $224.59M | 3 month · $3.18M | (m) |
| 2022-03-31 | (m) | $448.27M | $1.65M | $-190.81M | $259.57M | 3 month · $3.13M | (m) |
| 2021-12-31 | (m) | $444.75M | $8.84M | $-169.64M | $284.41M | 12 month · $8.64M | (m) |
| 2021-09-30 | (m) | $441.13M | $7.82M | $-143.99M | $305.42M | 3 month · $2.29M | (m) |
| 2021-06-30 | (m) | $438.82M | $16.22M | $-128.14M | $327.36M | 3 month · $1.90M | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | $188.50M | 3 month · $1.67M | (m) |
| 2020-12-31 | (m) | $279.48M | $14.59M | $-97.90M | $196.56M | 12 month · $17.98M | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | $203.07M | 3 month · $5.21M | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | $-44.85M | 3 month · $9.70M | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | $-37.62M | 3 month · $1.70M | (m) |
| 2019-12-31 | (m) | $7.16M | $-98.00K | $-37.56M | $-30.39M | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | $-14.37M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |